Cargando…

ECMO in COVID-19—prolonged therapy needed? A retrospective analysis of outcome and prognostic factors

BACKGROUND: The role of venovenous extracorporeal membrane oxygenation (VV ECMO) in patients with COVID-19-induced acute respiratory distress syndrome (ARDS) still remains unclear. Our aim was to investigate the clinical course and outcome of those patients and to identify factors associated with th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dreier, Esther, Malfertheiner, Maximilian Valentin, Dienemann, Thomas, Fisser, Christoph, Foltan, Maik, Geismann, Florian, Graf, Bernhard, Lunz, Dirk, Maier, Lars Siegfried, Müller, Thomas, Offner, Robert, Peterhoff, David, Philipp, Alois, Salzberger, Bernd, Schmidt, Barbara, Sinner, Barbara, Lubnow, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369905/ https://www.ncbi.nlm.nih.gov/pubmed/33612020 http://dx.doi.org/10.1177/0267659121995997

Ejemplares similares

Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: a propensity-score matched study
por: Fisser, Christoph, et al.
Publicado: (2021)

Factors associated with hemolysis during extracorporeal membrane oxygenation (ECMO)—Comparison of VA- versus VV ECMO
por: Appelt, Hannah, et al.
Publicado: (2020)

Recirculation in single lumen cannula venovenous extracorporeal membrane oxygenation: A non-randomized bi-centric trial
por: Fisser, Christoph, et al.
Publicado: (2022)

Corrigendum: Recirculation in single lumen cannula venovenous extracorporeal membrane oxygenation: A non-randomized bi-centric trial
por: Fisser, Christoph, et al.
Publicado: (2022)

Arterial and venous vascular complications in patients requiring peripheral venoarterial extracorporeal membrane oxygenation
por: Fisser, Christoph, et al.
Publicado: (2022)

Prognostic factors for favorable outcomes after veno-venous extracorporeal membrane oxygenation in critical care patients with COVID-19
por: Kieninger, Bärbel, et al.
Publicado: (2023)

Prevalence and outcomes of patients developing heparin-induced thrombocytopenia during extracorporeal membrane oxygenation
por: Lubnow, Matthias, et al.
Publicado: (2022)

Pitfalls in percutaneous ECMO cannulation
por: Rupprecht, L, et al.
Publicado: (2015)

Technical Complications during Veno-Venous Extracorporeal Membrane Oxygenation and Their Relevance Predicting a System-Exchange – Retrospective Analysis of 265 Cases
por: Lubnow, Matthias, et al.
Publicado: (2014)

Technical-Induced Hemolysis in Patients with Respiratory Failure Supported with Veno-Venous ECMO – Prevalence and Risk Factors
por: Lehle, Karla, et al.
Publicado: (2015)

Reliability of prognostic biomarkers after prehospital extracorporeal cardiopulmonary resuscitation with target temperature management
por: Petermichl, Walter, et al.
Publicado: (2021)

Coagulation abnormalities in patients with COVID‐19 on venovenous ECLS increased risk for technical complications and support times but had no impact on survival
por: Lehle, Karla, et al.
Publicado: (2022)

Lower blood pH as a strong prognostic factor for fatal outcomes in critically ill COVID-19 patients at an intensive care unit: A multivariable analysis
por: Kieninger, Martin, et al.
Publicado: (2021)

Evaluation of models for prognosing mortality in critical care patients with COVID-19: First- and second-wave data from a German university hospital
por: Kieninger, Martin, et al.
Publicado: (2022)

Accumulations of von Willebrand factor within ECMO oxygenators: Potential indicator of coagulation abnormalities in critically ill patients?
por: Steiger, Tamara, et al.
Publicado: (2019)

Secondary hemophagocytic lymphohistiocytosis and severe liver injury induced by hepatic SARS-CoV-2 infection unmasking Wilson’s disease: Balancing immunosuppression
por: Lubnow, Matthias, et al.
Publicado: (2021)

Severe T cell hyporeactivity in ventilated COVID-19 patients correlates with prolonged virus persistence and poor outcomes
por: Renner, Kerstin, et al.
Publicado: (2021)

Autopsy findings after long-term treatment of COVID-19 patients with microbiological correlation
por: Evert, Katja, et al.
Publicado: (2021)

Cardiac effects of induction agents in the septic rat heart
por: Zausig, York A, et al.
Publicado: (2009)

Early Findings after Implementation of Veno-Arteriovenous ECMO: A Multicenter European Experience
por: Blandino Ortiz, Aaron, et al.
Publicado: (2021)

Prolonged VV ECMO: Navigating the Unchartered Sea
por: Kumar, Vivek
Publicado: (2023)

A highly specific and sensitive serological assay detects SARS-CoV-2 antibody levels in COVID-19 patients that correlate with neutralization
por: Peterhoff, David, et al.
Publicado: (2020)

Acute Kidney Injury and Renal Regional Oxygen Saturation During Pediatric Liver Transplantation
por: Sinner, Barbara, et al.
Publicado: (2020)

Impact of dynamic changes of elevated bilirubin on survival in patients on veno-arterial extracorporeal life support for acute circulatory failure
por: Freundt, Miriam, et al.
Publicado: (2017)

Piloting an ICU follow-up clinic to improve health-related quality of life in ICU survivors after a prolonged intensive care stay (PINA): feasibility of a pragmatic randomised controlled trial
por: Drewitz, Karl Philipp, et al.
Publicado: (2023)

Necrotizing pneumonia requiring prolonged extracorporeal membrane oxygenation: Pushing the boundaries in pediatric ECMO
por: R. R., Pravin, et al.
Publicado: (2022)

Long-term follow-up and quality of life in patients receiving extracorporeal membrane oxygenation for pulmonary embolism and cardiogenic shock
por: Stadlbauer, Andrea, et al.
Publicado: (2021)

Editorial: Hemostasis in ECMO and VAD
por: Teruya, Jun, et al.
Publicado: (2019)

Piloting an ICU follow-up clinic to improve health-related quality of life in ICU survivors after a prolonged intensive care stay (PINA): study protocol for a pilot randomised controlled trial
por: Rohr, M., et al.
Publicado: (2021)

Life span of different extracorporeal membrane systems for severe respiratory failure in the clinical practice
por: Philipp, Alois, et al.
Publicado: (2018)

Increased neutralization of SARS-CoV-2 Delta variant after heterologous ChAdOx1 nCoV-19/BNT162b2 versus homologous BNT162b2 vaccination
por: Bauswein, Markus, et al.
Publicado: (2022)

The Prolonged Use of VV ECMO Support in COVID-19: A Case Report
por: Fitzgerald, Amelia Lucy, et al.
Publicado: (2020)

(591) Prolonged V.v.-Ecmo for Covid-19 Ards with Lung Recovery
por: Beckett, A., et al.
Publicado: (2023)

Pumpless extracorporeal interventional lung assist in patients with acute respiratory distress syndrome: a prospective pilot study
por: Zimmermann, Markus, et al.
Publicado: (2009)

Commentary: To ECMO or not to ECMO: That is the question
por: Worku, Berhane, et al.
Publicado: (2020)

ECMO use in Germany: An analysis of 29,929 ECMO runs
por: Bercker, Sven, et al.
Publicado: (2021)

Coronavirus disease 2019 induces multi‐lineage, morphologic changes in peripheral blood cells
por: Lüke, Florian, et al.
Publicado: (2020)

Extracorporeal circulatory systems in the interhospital transfer of critically ill patients: experience of a single institution
por: Haneya, Assad, et al.
Publicado: (2009)

Prolonged prone positioning under VV-ECMO is safe and improves oxygenation and respiratory compliance
por: Kimmoun, Antoine, et al.
Publicado: (2015)

THE LONG SWEEP: A CASE OF PROLONGED VENO-VENOUS ECMO IN COVID-19 PNEUMONIA
por: BAIN, ALEXANDER, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1vlc77rbdlibn9gveqjmukoele